-transparent.png){kind=logo}
We report the excellent therapeutic response obtained with amikacin alone and in combination with trimethoprim-sulfamethoxazole in the treatment of 15 patients with actinomycotic mycetoma who had a poor response to the traditional pharmacologic agents and/or in whom important organs such as lungs, spinal cord, and bone were involved. We evaluated the results by clinical, radiologic, and laboratory tests. No important side effects were detected during or after the therapy.
Related Publications
O Welsh, and
E Sauceda, and
J Gonzalez, and
J Ocampo
May 1993,
Archives of dermatology,
O Welsh, and
E Sauceda, and
J Gonzalez, and
J Ocampo
October 1975,
Archives of dermatology,
O Welsh, and
E Sauceda, and
J Gonzalez, and
J Ocampo
January 2022,
Indian journal of dermatology, venereology and leprology,
O Welsh, and
E Sauceda, and
J Gonzalez, and
J Ocampo
September 1982,
The New England journal of medicine,
O Welsh, and
E Sauceda, and
J Gonzalez, and
J Ocampo
January 1973,
Dermatologica,
O Welsh, and
E Sauceda, and
J Gonzalez, and
J Ocampo
January 1971,
Bulletin de la Societe francaise de dermatologie et de syphiligraphie,
O Welsh, and
E Sauceda, and
J Gonzalez, and
J Ocampo
January 1983,
Gastroenterology,
O Welsh, and
E Sauceda, and
J Gonzalez, and
J Ocampo
October 1972,
Bordeaux medical,
O Welsh, and
E Sauceda, and
J Gonzalez, and
J Ocampo
August 1978,
Chest,
O Welsh, and
E Sauceda, and
J Gonzalez, and
J Ocampo
February 1972,
Giornale di malattie infettive e parassitarie,
